Background and Aims Intrabiliary radiofrequency ablation (IB-RFA) is a therapeutic option for cases of positive margins or recurrence after endoscopic papillectomy (EP) for superficial neoplasia. We report our experience concerning safety and efficiency of IB-RFA. Patients and methods Single tertiary center retrospective study. All patients who underwent IB-RFA indicated in cases of residual or recurrent neoplasia after EP were included. We assessed morbidity (< 30 days) and late complication (> 30 days). Secondary outcomes were clinical success and late recurrence (absence of recurrence at the papillectomy site 12months after IB-RFA and beyond, respectively). Results: Twenty-five patients were included and underwent IB-RFA for deep positive margins (20/25, 80%) and relapse (5/25, 20%), 40 sessions were delivered. Morbidity rate was 8% (2/24) (one pancreatitis, one bleeding).Acute pancreatitis was significantly more common in the absence of pancreatic stenting (0% vs. 22%, p=0.046). One patient for whom pancreatic stenting failed died from acute severe pancreatitis in the first month (mortality rate = 4%). Late complications occurred in 12/24 patients (50%) concerning only biliary stricture, all managed endoscopically without sequelae. The clinical success rate was 92% (22/24), and late recurrence occurred in 2/24 patients (8%). Conclusions: IB-RFA is relatively safe and efficient in cases of residual or recurrent neoplasia after EP and is an alternative to surgery in well-selected cases. Biliary stricture occur frequently (50%) but are managed endoscopically without sequelae in all cases. In case of pancreatic stenting failure and because of the risk of severe acute pancreatitis potentially lethal, IB-RFA should be postpone.
Read full abstract